Skip to main content
    E

    Envista Holdings Corp (NVST)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $23.50
    +0.67 (+2.96%)

    Market Cap: $3.67B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    79%(22/28)
    Avg Surprise
    +22.87%
    Streak
    8 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.36
    Range$0.34 - $0.38
    15 analysts
    EPS RevisionsNo revisions (7d)
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$0.34+3.7%
    60d ago$0.36-0.9%
    30d ago$0.36-0.7%
    7d ago$0.36+0.1%
    Current$0.36
    Revenue Consensus
    $689M
    Range$684M - $701M
    13 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.53
    Range$0.49 - $0.55
    15 analysts
    Revenue Consensus
    $792M
    Range$781M - $805M
    14 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.53---
    Sep 26EST
    		-$0.36---
    Jun 26
    Reported Aug 5
    		$0.41$0.33+24.24%Beat+57.7%
    Mar 26
    Reported May 6
    		$0.36$0.31+16.13%Beat+50.0%
    Dec 25
    Reported Feb 5
    		$0.38$0.32+18.75%Beat+58.3%
    Sep 25
    Reported Oct 29
    		$0.32$0.28+14.29%Beat+166.7%
    Jun 25
    Reported Jul 31
    		$0.26$0.23+13.04%Beat+136.4%
    Mar 25
    Reported May 1
    		$0.24$0.20+20.00%Beat-7.7%
    Dec 24
    Reported Feb 5
    		$0.24$0.22+9.09%Beat-17.2%
    Sep 24
    Reported Oct 30
    		$0.12$0.09+33.33%Beat-72.1%
    Jun 24
    Reported Aug 7
    		$0.11N/A-60.71%Miss-74.4%
    Mar 24
    Reported May 1
    		$0.26$0.32-18.75%Miss-31.6%
    Dec 23
    Reported Feb 7
    		$0.29$0.34-14.71%Miss-44.2%
    Sep 23
    Reported Nov 1
    		$0.43$0.46-6.52%Miss-8.5%
    Jun 23
    Reported Aug 2
    		$0.43$0.41+4.88%Beat-10.4%
    Mar 23
    Reported May 3
    		$0.38$0.41-7.32%Miss-19.1%
    Dec 22
    Reported Feb 8
    		$0.52$0.49+6.12%Beat+13.0%
    Sep 22
    Reported Nov 3
    		$0.47$0.47+0.00%Beat+4.4%
    Jun 22
    Reported Aug 3
    		$0.48$0.46+4.35%Beat-9.4%
    Mar 22
    Reported May 4
    		$0.47$0.43+9.30%Beat-13.0%
    Dec 21
    Reported Feb 9
    		$0.46$0.42+9.52%Beat-17.9%
    Sep 21
    Reported Nov 3
    		$0.45$0.41+9.76%Beat-6.2%
    Jun 21
    Reported Aug 3
    		$0.53$0.45+17.78%Beat+630.0%
    Mar 21
    Reported May 5
    		$0.54$0.31+74.19%Beat+1700.0%
    Dec 20
    Reported Feb 10
    		$0.56$0.42+33.33%Beat+7.7%
    Sep 20
    Reported Oct 29
    		$0.48$0.09+433.33%Beat+2.1%
    Jun 20
    Reported Jul 30
    		$-0.10N/A+56.52%Beat-120.8%
    Mar 20
    Reported May 12
    		$0.03N/A-75.00%Miss-
    Dec 19
    Reported Jan 30
    		$0.52$0.49+6.12%Beat-
    Sep 19
    Reported Oct 24
    		$0.47$0.43+9.30%Beat-
    Jun 19
    Reported Jul 22
    		$0.48$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio15.98EV/EBITDA9.72x
    Price/FCF15.33xFCF Yield6.52%
    Profitability
    Profit Margin3.33%Operating Margin10.40%
    ROE3.06%ROIC3.88%
    Financial Health
    Debt/Equity0.47xInterest CoverageN/A
    Current Ratio2.43xQuick Ratio2.07x
    Trading Statistics
    Beta0.89Avg Volume2.89M
    52-Week High$30.4252-Week Low$18.77

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$23.05
    SMA 20$23.35
    SMA 50$25.57
    SMA 200$25.71
    EMA 10$23.13
    EMA 20$23.59
    EMA 50$24.76
    EMA 200$24.77

    MACD

    Line: -0.71Signal: -0.81Hist: 0.11

    ADX

    ADX: 32.1+DI: 17.9-DI: 26.9

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down92.0
    PSAR$22.20

    Bollinger Bands

    Upper Band$24.25
    Lower Band$22.45
    %B Position767%(Upper)
    Band Width0.58

    RSI (14-Day)

    Neutral
    44.5

    Momentum Oscillators

    Stoch %K41.3
    Stoch %D30.4
    Williams %R-30.0
    ROC (10d)1.4%
    Momentum0.34
    CCI (20d)-32.3
    MFI (14d)43.0

    Volatility Measures

    ATR (14d)$0.70(3.0%)
    StdDev (20d)0.45
    Hist Vol22.8%(Moderate)

    Volume Flow

    VWAP$23.17
    OBV33.3M
    AD Line-13.1M
    CMF (20d)0.037

    Volume Metrics

    Avg Vol (20d)2.8M
    Vol Ratio1.3x
    VWMA (20d)$23.40

    Pivot Points

    R3$23.42
    R2$23.19
    R1$23.00
    Pivot Point$22.77
    S1$22.58
    S2$22.35
    S3$22.16

    Advanced Oscillators

    TSI-30.72
    Ultimate Osc54.9
    KST-106.95

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$730.50M$705.50M$750.60M$669.90M$682.10M$616.90M$652.90M$601.00M$633.10M$623.60M$645.60M$631.30M
    Cost of Revenue$323.50M$315.40M$340.00M$299.70M$312.20M$280.90M$280.40M$283.70M$306.50M$267.30M$309.70M$268.00M
    Gross Profit$407.00M$390.10M$410.60M$370.20M$369.90M$336.00M$372.50M$317.30M$326.60M$356.30M$335.90M$363.30M
    Operating Expenses$326.70M$327.60M$337.30M$312.70M$323.60M$297.00M$326.40M$296.40M$1.48B$308.20M$538.70M$280.00M
    R&D$30.40M$30.00M$32.10M$28.30M$28.30M$25.30M$26.70M$25.50M$23.60M$23.30M$20.20M$22.30M
    SG&A$296.30M$297.60M$305.20M$284.40M$295.30M$271.70M$299.70M$270.90M$302.50M$284.90M$260.20M$257.70M
    Operating Income$80.30M$62.50M$73.30M$57.50M$46.30M$39.00M$46.10M$20.90M$-1,153,300,000$48.10M$-202,800,000$83.30M
    Interest Income$-8,700,000$-7,400,000$-10,300,000$-9,000,000$-8,000,000$-9,300,000$-9,900,000$-11,900,000$-11,700,000$-12,900,000$0$-15,400,000
    Interest Expense$5.90M$10.30M$15.70M$7.60M$5.60M$10.00M$9.60M$11.30M$12.80M$12.80M$12.20M$47.50M
    Income Before Tax$74.40M$52.20M$57.60M$49.90M$40.70M$29.00M$36.50M$9.60M$-1,166,100,000$35.30M$-215,000,000$35.80M
    Income Tax Expense$20.70M$13.50M$24.70M$80.20M$14.30M$11.00M$35.30M$1.40M$-14,500,000$11.70M$2.40M$14.30M
    Net Income$53.70M$38.70M$32.90M$-30,300,000$26.40M$18.00M$1.20M$8.20M$-1,151,600,000$23.60M$-217,400,000$21.50M
    EBITDA$111.90M$89.80M$132.70M$89.10M$79.60M$67.30M$75.40M$52.10M$-1,119,300,000$81.50M$-167,000,000$85.30M
    EBIT$83.10M$59.60M$67.90M$58.90M$48.70M$38.30M$46.40M$21.50M$-1,154,400,000$48.20M$-201,100,000$51.20M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NVST

    News

    Piper Sandler cuts Envista stock price target on inventory headwinds By Investing.com

    Piper Sandler has lowered its price target for Envista Holdings Corp. (NYSE:NVST) to $26 from $28, maintaining a Neutral rating due to inventory drawdown headwinds in the company's orthodontic business. The firm adjusted...

    Investing.com Canada•10/9/26•Bearish

    Piper Sandler cuts Envista stock price target on inventory headwinds

    Piper Sandler has reduced its price target for Envista Holdings Corp. (NVST) to $26 from $28, while maintaining a Neutral rating...

    Investing.com•10/9/26•Neutral

    Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Stryker (SYK)

    Two healthcare companies, Envista Holdings (NVST) and Stryker (SYK), recently received bullish ratings from analysts. Envista Holdings was reiterated with a Buy rating and a $34.00 price target by Bank of America...

    The Globe and Mail•10/8/26•Bullish

    Envista Holdings Corporation (NVST) Stock forecasts

    This article provides a stock forecast for Envista Holdings Corporation (NVST), a dental products company. Argus reports on NVST...

    Yahoo Finance Singapore•10/8/26•Neutral

    Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Stryker (SYK)

    Two healthcare companies, Envista Holdings (NVST) and Stryker (SYK), recently received bullish sentiments from analysts. Bank of America Securities reiterated a Buy rating for Envista Holdings with a $34.00 price target...

    The Globe and Mail•10/8/26•Bullish

    NVST Valuation and Fair Value

    P/E
    16.0x
    Forward P/E
    16.8x
    EV/EBITDA
    9.7x
    P/FCF
    15.3x
    P/B
    1.2x
    See GNG's fair value

    NVST Profitability: Margins, ROIC and FCF

    Gross margin
    55.2%
    Operating margin
    10.4%
    Net margin
    3.3%
    ROIC
    3.9%
    ROE
    3.1%
    FCF margin
    8.7%
    FCF yield
    6.5%

    NVST Competitors

    CompanyTicker
    Tango Therapeutics IncTNGX
    Telix Pharmaceuticals LimitedTLX
    Catalyst Pharmaceuticals IncCPRX
    National HealthCare CorporationNHC
    Edgewise Therapeutics IncEWTX
    Organon & CoOGN
    Indivior PLC Ordinary SharesINDV
    iRhythm Technologies IncIRTC

    Sector: Healthcare

    NVST Analyst Ratings

    Consensus
    Buy
    Analysts
    15
    Strong Buy
    2
    Buy
    6
    Hold
    7
    Sell
    0
    Strong Sell
    0

    NVST Bull Case vs Bear Case

    Bull case

    • NVST beat EPS estimates in 100.0% of its last 8 reported quarters.

    NVST Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    18.6%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.36
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 3 down

    Frequently Asked Questions About NVST

    Does NVST pay dividends?

    Envista Holdings Corp (NVST) does not currently pay a regular dividend.

    What is NVST's P/E ratio?

    Envista Holdings Corp has a price-to-earnings (P/E) ratio of 15.98.

    What is NVST's market cap?

    Envista Holdings Corp (NVST) has a market capitalization of $3.67B with a current stock price of $23.50.

    Related stocks

    Sector: Healthcare

    All stocks starting with N

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In